Physical and Functional Interaction between the Dopamine Transporter and the Synaptic Vesicle Protein Synaptogyrin-3
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Uptake through the dopamine transporter (DAT) represents the primary mechanism used to terminate dopaminergic transmission in brain. Although it is well known that dopamine (DA) taken up by the transporter is used to replenish synaptic vesicle stores for subsequent release, the molecular details of this mechanism are not completely understood. Here, we identified the synaptic vesicle protein synaptogyrin-3 as a DAT interacting protein using the split ubiquitin system. This interaction was confirmed through coimmunoprecipitation experiments using heterologous cell lines and mouse brain. DAT and synaptogyrin-3 colocalized at presynaptic terminals from mouse striatum. Using fluorescence resonance energy transfer microscopy, we show that both proteins interact in live neurons. Pull-down assays with GST (glutathione S-transferase) proteins revealed that the cytoplasmic N termini of both DAT and synaptogyrin-3 are sufficient for this interaction. Furthermore, the N terminus of DAT is capable of binding purified synaptic vesicles from brain tissue. Functional assays revealed that synaptogyrin-3 expression correlated with DAT activity in PC12 and MN9D cells, but not in the non-neuronal HEK-293 cells. These changes were not attributed to changes in transporter cell surface levels or to direct effect of the protein–protein interaction. Instead, the synaptogyrin-3 effect on DAT activity was abolished in the presence of the vesicular monoamine transporter-2 (VMAT2) inhibitor reserpine, suggesting a dependence on the vesicular DA storage system. Finally, we provide evidence for a biochemical complex involving DAT, synaptogyrin-3, and VMAT2. Collectively, our data identify a novel interaction between DAT and synaptogyrin-3 and suggest a physical and functional link between DAT and the vesicular DA system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Molecular anatomy of a trafficking organelle
Takamori, S., Holt, M., Stenius, K., Lemke, E. A., Grønborg, M., Riedel, D., Urlaub, H., Schenck, S., Brügger, B., Ringler, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.030 · Cited by 2,373
Drug addiction: bad habits add up
Robbins, T. W., & Everitt, B. J. (1999) · Nature · doi:10.1038/19208 · Cited by 599 · cited 2×
“…target for therapeutic agents used in the treatment of mental disorders such as ADHD and depression as well as for cocaine and amphetamine, which are highly addictive and are major substances of abuse worldwide (Barker and Blakely, 1995; Amara and Sonders, 1998; Robbins and Everitt, 1999).”
BackgroundNeurobiologic processes in drug reward and addiction
Adinoff, B. (2004) · Harvard Review of Psychiatry · doi:10.1080/10673220490910844 · Cited by 546 · cited 2×
“…neurological and psychiatric conditions such as Parkinson’s disease, dystonia, depression, schizophrenia, attention deficit/hyperactivity disorder (ADHD), Tourette’s syndrome, and drug addiction (Carlsson, 1987; Roth and Elsworth, 1995; Koob and Le Moal, 1997; Greengard, 2001; Adinoff, 2004).”
BackgroundMorphological correlates of functionally defined synaptic vesicle populations
Schikorski, T., & Stevens, C. F. (2001) · Nature Neuroscience · doi:10.1038/86042 · Cited by 516 · cited 1×
“The latter is clearly evident in experiments using electron microscopy of nerve terminals (Schikorski and Stevens, 2001).”
BackgroundImaging studies on the role of dopamine in cocaine reinforcement and addiction in humans
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300406 · Cited by 315 · cited 1×
“Reduction of monoamine levels in brain has also been observed after chronic treatment with monoamine transporter inhibitors in mice (Avni et al., 1975; Rattray, 1991; Wilson et al., 1996; Wu et al., 1997; Baumann et al., 1998; Volkow et al., 1999; Wang et al., 1999; Mateo et al., 2005).”
BackgroundThe Neurobiology of Dopamine Signaling
Greengard, P. (2001) · Bioscience Reports · doi:10.1023/a:1013205230142 · Cited by 133
Synaptic distribution of the endocytic accessory proteins AP180 and CALM
Yao, P. J., Petralia, R. S., Bushlin, I., Wang, Y., & Furukawa, K. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20362 · Cited by 49 · cited 1×
“Additional evidence indicates that the machinery involved in synaptic vesicle recycling for clathrin-mediated endocytosis is away from the active site (Yao et al., 2005, and references therein).”
Background
Cited by
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Mechanisms of dopamine transporter regulation in normal and disease states
Vaughan, R. A., & Foster, J. D. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.07.005 · Cited by 419
“Our current understanding of the physiological significance of these events is low, but it has been speculated that the ability of Syn1A to induce vesicular neurotransmitter release but inhibit transmitter reuptake may represent a mechanism for spatial or temporal coordination of these processes [59, 60].”
Amphetamines, new psychoactive drugs and the monoamine transporter cycle
Sitte, H. H., & Freissmuth, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.11.006 · Cited by 276
Self-citationDopamine transporters govern diurnal variation in extracellular dopamine tone
Ferris, M. J., España, R. A., Locke, J. L., Konstantopoulos, J. K., Rose, J. H., Chen, R., & Jones, S. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407935111 · Cited by 192
“Indeed, the DAT has been explicitly linked to the recycling of [DA]ext and the filling of readily releasable vesicles (35, 36).”
BackgroundResultReddy, I. A., Pino, J. A., Weikop, P., Osses, N., Sørensen, G., Bering, T., Valle, C., Bluett, R. J., Erreger, K., Wortwein, G., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.86 · Cited by 96
Self-citation
Metadata
- Authors
- Egaña, L. A., Cuevas, R. A., Baust, T. B., Parra, L. A., Leak, R. K., Hochendoner, S., Peña, K., Quiroz, M., Hong, W. C., Dorostkar, M. M., Janz, R., Sitte, H. H., & Torres, G. E.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-04-08
- Volume
- 29
- Issue
- 14
- Pages
- 4592-4604
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2118964451
- Cited by
- 146
- References
- 8
- FWCI
- 3.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Physical and Functional Interaction between the Dopamine Transporter and the Synaptic Vesicle Protein Synaptogyrin-3. https://app.cochat.ai/papers/10.1523/jneurosci.4559-08.2009
- The paper
- Egaña, L. A., Cuevas, R. A., Baust, T. B., Parra, L. A., Leak, R. K., Hochendoner, S., Peña, K., Quiroz, M., Hong, W. C., Dorostkar, M. M., Janz, R., Sitte, H. H., & Torres, G. E. (2009). Physical and Functional Interaction between the Dopamine Transporter and the Synaptic Vesicle Protein Synaptogyrin-3. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.4559-08.2009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.